Impact of Lactobacillus reuteri DSM 17938 on infant colic and parent mental health: a randomised double-blinded, placebo-controlled trial in breast and formula fed infants less than 3 months old.

Trial Profile

Impact of Lactobacillus reuteri DSM 17938 on infant colic and parent mental health: a randomised double-blinded, placebo-controlled trial in breast and formula fed infants less than 3 months old.

Completed
Phase of Trial: Phase IV

Latest Information Update: 18 Feb 2015

At a glance

  • Drugs Lactobacillus reuteri (Primary)
  • Indications Colic
  • Focus Therapeutic Use
  • Most Recent Events

    • 01 Apr 2014 Primary endpoint 'Duration-of-symptoms' has not been met.
    • 01 Apr 2014 Results published in the BMJ.
    • 01 May 2013 Status changed from recruiting to completed as reported by ISRCTN.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top